Table 1

Oligonucleotide sequence and modifications

CompoundMolecular TargetSequence (5′ → 3′)
ISIS 1082Herpes virusGsCsCsGsAsGsGsTsCsCsAsTsGsTsCsGsTsAsCsGsC
ISIS 13108Herpes virusGsC*sC*sGsAsGsGsTsC*sC*sAsTsGsTsC*sGsTsAsC*sGsC*
ISIS 12449NoneAsCsCsGsAsTsAsAsCsGsTsTsGsCsCsGsGsTsGsAsCsG
ISIS 5132Human C-raf kinaseTsCsCsCsGsCsCsTsGsTsGsAsCsAsTsGsCsAsTsT
ISIS 12959Baboon C-raf kinaseTsCsTsCsAsCsCsTsGsTsGsAsCsAsTsGsCsAsTsT
ISIS 12854Human C-raf kinase ToC*oC*oC*oGoCsCsTsGsTsGsAsCsAsToGoC*oAoToT
ISIS 13650Human C-raf kinase TsC*sC*sC*sG7sCsCsTsGsTsGsAsCsAsTsGsC*sAsTsT
  • C, deoxynucleotide; C*, 5-methyl C; T, 2′-MDE; s, phosphorothioate linkage; and o, phosphodiester linkage.